Skip to main navigation Skip to search Skip to main content

Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain

  • Jamie Karagianis
  • , Vicki Poole Hoffmann
  • , Belen Arranz
  • , Tamás Treuer
  • , Gerald A. Maguire
  • , Lieuwe de Haan
  • , Bharat Chawla

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Several papers and communications have reported possible weight reduction or less weight gain when patients start or switch to orally disintegrating olanzapine, as contrasted with standard oral olanzapine tablets. In this paper, the current literature is reviewed and hypothesized mechanisms of action are discussed. The data are still preliminary and mechanisms of action are not well understood. Randomized controlled trials are needed to further evaluate change in weight during treatment with orally disintegrating olanzapine
Original languageEnglish
Pages (from-to)275-281
JournalHuman psychopharmacology
Volume23
Issue number4
DOIs
Publication statusPublished - 2008

Fingerprint

Dive into the research topics of 'Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain'. Together they form a unique fingerprint.

Cite this